Balili, Angel S.

HRN: 28-85-53  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/16/2026
CEFUROXIME 500MG (TAB)
04/16/2026
04/22/2026
PO
500mg
BID
For Completion Curettage
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: